Charles E. Dadswell net worth and biography

Charles Dadswell Biography and Net Worth

Charles E. Dadswell is the Senior Vice President, General Counsel, Secretary of Illumina Inc. since April 22, 2013. Mr. Dadswell joins Illumina with more than 20 years of leadership and legal experience at health care-focused technology companies. Most recently, he was Vice President, General Counsel for North and Latin America and Corporate Director of Global Intellectual Property at bioMerieux. In this role, he was responsible for a global intellectual property matters and legal matters in North and Latin America. Prior to bioMerieux, he was General Counsel of BioDelivery Sciences International, a specialty pharmaceutical company; and oversaw US intellectual property in a variety of positions with Glaxo, GlaxoWellcome and GlaxoSmithKline. Mr. Dadswell holds a LLM in patent law and trade regulation from The George Washington University Law School, a JD from the Thomas M. Cooley Law School and a bachelor's in science from Ferris State University.

What is Charles E. Dadswell's net worth?: The estimated net worth of Charles E. Dadswell is at least $1.65 million as of April 28th, 2022. Mr. Dadswell owns 7,427 shares of Illumina stock worth more than $1,645,897 as of March 22nd. This net worth estimate does not reflect any other investments that Mr. Dadswell may own. Learn More about Charles E. Dadswell's net worth.
How do I contact Charles E. Dadswell?: The corporate mailing address for Mr. Dadswell and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected] Learn More on Charles E. Dadswell's contact information.
Has Charles E. Dadswell been buying or selling shares of Illumina?: Charles E. Dadswell has not been actively trading shares of Illumina during the last quarter. Most recently, Charles Dadswell sold 368 shares of the business's stock in a transaction on Thursday, April 28th. The shares were sold at an average price of $300.13, for a transaction totalling $110,447.84. Following the completion of the sale, the senior vice president now directly owns 7,427 shares of the company's stock, valued at $2,229,065.51. Learn More on Charles E. Dadswell's trading history.
Who are Illumina's active insiders?: Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.
Are insiders buying or selling shares of Illumina?: In the last year, insiders at the life sciences company sold shares 14 times. They sold a total of 18,673 shares worth more than $4,563,255.41. The most recent insider tranaction occured on March, 1st when SVP Aimee L Hoyt sold 3,917 shares worth more than $779,718.02. Insiders at Illumina own 0.1% of the company. Learn More about insider trades at Illumina.
Information on this page was last updated on 3/1/2023.

Charles E. Dadswell Insider Trading History at Illumina

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/28/2022	Sell	368	$300.13	$110,447.84	7,427
3/28/2022	Sell	368	$342.83	$126,161.44
12/22/2021	Sell	322	$380.29	$122,453.38
11/22/2021	Sell	314	$377.86	$118,648.04
10/22/2021	Sell	314	$411.00	$129,054.00
9/22/2021	Sell	314	$436.69	$137,120.66
8/23/2021	Sell	314	$489.10	$153,577.40
7/22/2021	Sell	314	$482.23	$151,420.22
6/22/2021	Sell	314	$461.01	$144,757.14
4/22/2021	Sell	314	$402.02	$126,234.28	6,518
3/22/2021	Sell	314	$416.24	$130,699.36	6,832
12/1/2020	Sell	1,694	$323.86	$548,618.84	3,460
10/1/2020	Sell	121	$312.82	$37,851.22	6,157
8/3/2020	Sell	121	$385.19	$46,607.99	7,913
4/1/2020	Sell	121	$265.92	$32,176.32	9,962
12/2/2019	Sell	655	$320.33	$209,816.15	11,803
11/1/2019	Sell	193	$297.28	$57,375.04	5,069
9/3/2019	Sell	1,220	$279.88	$341,453.60	5,386
8/1/2019	Sell	124	$300.00	$37,200.00
7/1/2019	Sell	124	$371.29	$46,039.96
6/3/2019	Sell	1,220	$309.70	$377,834.00	8,006
5/1/2019	Sell	124	$311.77	$38,659.48	8,086
4/1/2019	Sell	124	$314.45	$38,991.80	8,210
3/1/2019	Sell	1,220	$313.93	$382,994.60
2/1/2019	Sell	124	$280.11	$34,733.64	6,879
1/2/2019	Sell	124	$294.71	$36,544.04	7,003
12/3/2018	Sell	566	$343.57	$194,460.62	5,606
4/3/2018	Sell	116	$230.91	$26,785.56	7,875
3/5/2018	Sell	145	$227.17	$32,939.65	7,991
2/5/2018	Sell	1,610	$221.45	$356,534.50	5,581
1/3/2018	Sell	145	$224.50	$32,552.50	7,411
12/4/2017	Sell	145	$225.33	$32,672.85	6,388
11/3/2017	Sell	1,609	$207.88	$334,478.92	7,217
10/3/2017	Sell	145	$202.23	$29,323.35
9/5/2017	Sell	145	$205.71	$29,827.95
8/3/2017	Sell	1,609	$197.00	$316,973.00	9,037
7/3/2017	Sell	145	$174.24	$25,264.80	10,646
6/5/2017	Sell	145	$184.75	$26,788.75	10,791
5/3/2017	Sell	1,609	$187.07	$300,995.63	10,936
2/6/2017	Sell	572	$161.26	$92,240.72	7,592
1/10/2017	Sell	116	$161.60	$18,745.60
10/4/2016	Sell	116	$182.38	$21,156.08	39,900
7/27/2016	Sell	8,632	$155.00	$1,337,960.00	40,248
4/4/2016	Sell	8,382	$167.81	$1,406,583.42	54,970
3/8/2016	Sell	8,382	$155.63	$1,304,490.66	66,507
3/7/2016	Sell	116	$155.00	$17,980.00	66,507
12/28/2015	Sell	168	$188.63	$31,689.84	41,830
11/3/2015	Sell	158	$150.00	$23,700.00	40,847
1/27/2015	Sell	224	$198.90	$44,553.60

Charles E. Dadswell Buying and Selling Activity at Illumina

Illumina Company Overview

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Today's Range

Now: $221.61

$218.55

$222.55

50 Day Range

MA: $209.65

$193.75

$228.15

2 Week Range

Now: $221.61

$173.45

$371.16

Volume

1,015,830 shs

Average Volume

1,458,294 shs

Market Capitalization

$35.01 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15

Stocks Positioned For The Year

From PressReach | Ad

This breakthrough stock has bright future this decade.

Learn more today.